Reuters logo
BRIEF-Idorsia Announces Collaboration With Janssen Biotech On Aprocitentan
December 4, 2017 / 6:04 AM / 13 days ago

BRIEF-Idorsia Announces Collaboration With Janssen Biotech On Aprocitentan

Dec 4 (Reuters) - IDORSIA LTD:

* IDORSIA ANNOUNCES COLLABORATION WITH JANSSEN BIOTECH ON APROCITENTAN (ACT-132577)

* ‍TO RECEIVE MILESTONE PAYMENT OF USD 230 MILLION​

* IDORSIA AND JANSSEN BIOTECH TO SHARE COSTS OF PHASE 3 DEVELOPMENT EQUALLY

* ‍ENTITLED TO ROYALTY PAYMENTS ON POTENTIAL FUTURE NET SALES​

* FOLLOWING JANSSEN‘S OPT-IN DECISION, IDORSIA WILL RECEIVE A ONE-TIME MILESTONE PAYMENT OF USD 230 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below